Literature DB >> 738347

Comparison of the pharmacodynamic effect of muzolimine and furosemide in patients with advanced chronic renal insufficiency.

P Schmidt, D Loew, J Dýcka, H Kopsa, P Balcke, J Zazgornik, E Deutsch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 738347     DOI: 10.1007/bf00716380

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  3-Amino-1-(3,4-dichloro-alpha-methyl-benzyl)-2-pyrazolin-5-one (Bay g 2821), a potent diuretic from a new substance class.

Authors:  E Möller; H Horstmann; K Meng; D Loew
Journal:  Experientia       Date:  1977-03-15

2.  Pharmacology of Bay g 2821, a long-acting, high-ceiling diuretic.

Authors:  K Meng; D Loew; K Stoepel; F Hoffmeister
Journal:  Curr Med Res Opin       Date:  1977       Impact factor: 2.580

3.  [Possibilities and limitations of high dosage diuretic therapy in hydropic renal insufficiency].

Authors:  A Heidland; K Klütsch; A Moormann; H Hennemann
Journal:  Dtsch Med Wochenschr       Date:  1969-08-01       Impact factor: 0.628

4.  Clinical use of furosemide.

Authors:  F C Reubi
Journal:  Ann N Y Acad Sci       Date:  1966-11-22       Impact factor: 5.691

5.  Diuretics in chronic renal disease: a study of high dosage frusemide.

Authors:  M E Allison; A C Kennedy
Journal:  Clin Sci       Date:  1971-09       Impact factor: 6.124

6.  Diuretic action of Bay g 2821 in oedema-free volunteers.

Authors:  D Loew
Journal:  Curr Med Res Opin       Date:  1977       Impact factor: 2.580

7.  Diuretic effects of Bay g 2821 in patients with advanced renal failure.

Authors:  A Röckel
Journal:  Curr Med Res Opin       Date:  1977       Impact factor: 2.580

8.  [The effect of acute diuresis augmentation on urea and creatinine clearance in healthy people and in patients with chronic renal insufficiency (author's transl)].

Authors:  P Endres; R Kley; R Heintz
Journal:  Klin Wochenschr       Date:  1975-06-15

9.  Diuretic action of bumetanide in advanced chronic renal insufficiency.

Authors:  K J Berg; A Tromsdal; T E Wideroe
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

10.  [Investigations into urea elimination in patients with advanced chronic renal failure during forced diuresis].

Authors:  H Quirin; G Schaeffer; R Kluthe
Journal:  Dtsch Med Wochenschr       Date:  1976-06-11       Impact factor: 0.628

  10 in total
  4 in total

1.  Comparison of the effects of muzolimine and furosemide in patients with end-stage renal failure on chronic dialysis.

Authors:  P Schmidt; D Loew; J Dycka; H Kopsa; P Balcke; J Zazgornik; E Deutsch
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

2.  Bioavailability and elimination kinetics of the combination furosemide-retard/triamterene.

Authors:  O Schuster; D Loew; H E Knoell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Apr-Jun       Impact factor: 2.441

3.  Serum lipoproteins in patients with mild renal disease treated with the diuretic muzolimine.

Authors:  H Schiffl; P Weidmann; R Mordasini; K Boehringer; W Riesen; C Bachmann
Journal:  Klin Wochenschr       Date:  1982-12-01

4.  Antihypertensive mechanism of the diuretic muzolimine in mild renal failure. Roles of sodium and cardiovascular norepinephrine responsiveness.

Authors:  H Schiffl; P Weidmann; C Beretta-Piccoli; C Cottier; A J Seiler; W H Ziegler
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.